Clinical Trial Update: Phase II Trial of SAHA & Tamoxifen for Patients With Breast Cancer [Phase 2]

View source ↗

Summary

This document reports the completion and results posting of a Phase II trial evaluating SAHA (vorinostat) in combination with tamoxifen for breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• SAHA (vorinostat)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: H. Lee Moffitt Cancer Center and Research Institute | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-03-26